Market starts off 2023 with a bang, rebounds for winning week. Plus, a new Alzheimer’s drug approval. 1/6/23
Stocks rally Friday after a seemingly ‘goldilocks’ jobs report, with consumer-leveraged stocks among the biggest winners. Plus, an exclusive with the EISAI US CEO - which worked with Biogen on the FDA’s approval of its Alzheimer’s treatment that slowed cognitive decline in a clinical trial.
More description
Stocks rally Friday after a seemingly ‘goldilocks’ jobs report, with consumer-leveraged stocks among the biggest winners. Plus, an exclusive with the EISAI US CEO - which worked with Biogen on the FDA’s approval of its Alzheimer’s treatment that slowed cognitive decline in a clinical trial.
2023-01-06
22 min
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in
Chapters
No chapters available.